Brian E. Mcdowell

Array ( [id] => 10498539 [patent_doc_number] => 09226929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Pharmaceutically active disubstituted triazine derivatives' [patent_app_type] => utility [patent_app_number] => 14/002730 [patent_app_country] => US [patent_app_date] => 2012-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26662 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212816 [patent_doc_number] => 20140011993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'PROCESS FOR PREPARING SILICA PARTICLES CONTAINING A PHTHALOCYANINE DERIVATIVE BY MICROWAVE IRRADIATION, SAID PARTICLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/984287 [patent_app_country] => US [patent_app_date] => 2012-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7515 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857587 [patent_doc_number] => 08883786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Glucocorticoid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/371834 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44340 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638367 [patent_doc_number] => 20130030170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'ENANTIOSELECTIVE CYCLOPROPENATION OF ALKYNES' [patent_app_type] => utility [patent_app_number] => 13/364570 [patent_app_country] => US [patent_app_date] => 2012-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17529 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199386 [patent_doc_number] => 20120122855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'BENZOXAZINES, BENZOTHIAZINES, AND RELATED COMPOUNDS HAVING NOS INHIBITORY ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/360029 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 64480 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122855.pdf [firstpage_image] =>[orig_patent_app_number] => 13360029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324432 [patent_doc_number] => 20120196838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES' [patent_app_type] => utility [patent_app_number] => 13/358020 [patent_app_country] => US [patent_app_date] => 2012-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24226 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13358020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538362 [patent_doc_number] => 20140163009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/981107 [patent_app_country] => US [patent_app_date] => 2012-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51333 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940688 [patent_doc_number] => 20130190486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'Method Of Mass Production Of Tetrakis(P-Nitrophenyl)Porphyrins' [patent_app_type] => utility [patent_app_number] => 13/354352 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3692 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9463958 [patent_doc_number] => 20140128385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'BACE-2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/979452 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 200876 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199380 [patent_doc_number] => 20120122854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Carbocyclic Fused Cyclic Amines' [patent_app_type] => utility [patent_app_number] => 13/347820 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18014 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122854.pdf [firstpage_image] =>[orig_patent_app_number] => 13347820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244930 [patent_doc_number] => 08202859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Heterocyclic sulfonamides' [patent_app_type] => utility [patent_app_number] => 13/330356 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18626 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202859.pdf [firstpage_image] =>[orig_patent_app_number] => 13330356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160347 [patent_doc_number] => 20120101082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'VASOPRESSIN V1A ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/329476 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90747 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101082.pdf [firstpage_image] =>[orig_patent_app_number] => 13329476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278504 [patent_doc_number] => 20120172380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'NOVEL 4-(TETRAZOL-5-YL)-QUINAZOLINE DERIVATIVES AS ANTI CANCER AGENT' [patent_app_type] => utility [patent_app_number] => 13/330304 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10616 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664682 [patent_doc_number] => 08378143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Methods of making Efavirens and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 13/330381 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9469 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866868 [patent_doc_number] => 20130150571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'Colored Polysiloxanes' [patent_app_type] => utility [patent_app_number] => 13/323747 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9439 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141357 [patent_doc_number] => 20120095229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'CHEMICAL PROCESS' [patent_app_type] => utility [patent_app_number] => 13/314034 [patent_app_country] => US [patent_app_date] => 2011-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22630 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095229.pdf [firstpage_image] =>[orig_patent_app_number] => 13314034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9198859 [patent_doc_number] => 20130338173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'Carbocycle-Substituted Purine And 7-Deazapurine Compounds' [patent_app_type] => utility [patent_app_number] => 13/991145 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62596 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9108332 [patent_doc_number] => 20130281464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'BIGUANIDE DERIVATIVE COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/991344 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5738 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211933 [patent_doc_number] => 20120130072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES' [patent_app_type] => utility [patent_app_number] => 13/308418 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11787 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20120130072.pdf [firstpage_image] =>[orig_patent_app_number] => 13308418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113308 [patent_doc_number] => 08569482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Nanoparticulate probe for in vivo monitoring of tissue oxygenation' [patent_app_type] => utility [patent_app_number] => 13/306565 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 34122 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306565 [rel_patent_id] =>[rel_patent_doc_number] =>)